Brief: Advicenne To Resume Phase III Trial Of ADV7103 In USA In June

Advicenne SA

17/05/2021 17:15

May 17 (Reuters) - ADVICENNE SA  ADVIC.PA :
    * FDA ACCEPTS AMENDED PROTOCOL AND ADVICENNE TO RESUME PHASE
III
TRIAL OF ITS FLAGSHIP PRODUCT ADV7103 (SIBNAYAL ™) IN THE UNITED
STATES IN JUNE 2021

Source text for Eikon:  ID:nGNEfhqgP 
Further company coverage:  ADVIC.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))